When DNA is coiled up into chromatin, it’s inaccessible to transcription, and genes are therefore silent. When it’s uncoiled, genes are active. This process, normally controlled by methyl groups, is called epigenetics. Chroma Medicine designs programmable epigenetic editors with effector domains that create precise, durable methylation patterns — thus activating, silencing, or tuning expression of targeted genes, in a way that’s safer and more predictable than alternative gene editing approaches that cut or alter DNA sequences.
In The Media
Explore Companies
Syntax Bio
Programming stem cells to differentiate into desired cell types, faster
Fable Therapeutics
Using state-of-the-art machine learning models to create custom-build protein drugs
Nilo Therapeutics
Mapping the brain-body axis to achieve proper immune balance
Avicenna Biosciences
Using AI to speed through the last mile of drug discovery